Host and viral factors influencing heterosexual HIV transmission. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Host and viral factors influencing heterosexual HIV transmission.

Rev Reprod. 1998 Jan;3(1):42-51. Unique Identifier : AIDSLINE MED/98168806
Miller CJ; California Regional Primate Research Center and Department of; Pathology, Microbiology and Immunology, School of Veterinary Medicine,; University of California, Davis 95616, USA.


Abstract: The World Health Organization estimates that 28-30 million people have been infected with human immunodeficiency virus (HIV). Although many important questions remain, much has been learned regarding the biology of heterosexual HIV transmission. For example, most sexual transmission of HIV is probably mediated by cell-free virus. Langerhans cells in the vaginal epithelium and dendritic cells or macrophages in the lamina propria are the most likely target cells in HIV transmission. Although there is restriction in the genotypes of viruses that are sexually transmitted, the common phenotypic characteristic of these viruses does not appear to be related to in vitro measures of tropism but rather to the relatively high in vivo replicative fitness of the transmitted viral variants. Clearly, host factors such as the amount of HIV-1 co-receptor expression on host cells and the presence of ulcerative sexually transmitted diseases affect the susceptibility of an individual to HIV infection. The growing body of information has increased the likelihood that a vaccine capable of preventing HIV-1 infection after exposure during sexual activity will be developed in the foreseeable future.
Keywords: *Heterosexuality *HIV/PHYSIOLOGY *HIV Infections/TRANSMISSION

KWDheterosexualityKWDhiv/physiologyKWDhivinfections/transmission
980730
M9871331


Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .